Palliative Oxygen Versus Room Air for Refractory Dyspnea (DRAFT)
Keyword(s):
Palliative oxygen therapy is used for treating dyspnea in patients with cancer and advanced cardiopulmonary diseases, however, small trials have suggested that circulating air may be just as effective. This international, multicenter, randomized controlled trial compared oxygen versus room air delivered by a nasal cannula for relief of dyspnea for patients with any life-limiting illness. Patients were adults >18 years of age, with PaO2 > 7.3kPa, on optimized therapies for their illness, and an expected survival of >1 month. The study demonstrated no clinically significant symptomatic benefit of palliative oxygen versus room air delivered via nasal cannula for seven days in patients with life-limiting illnesses and refractory dyspnea.
2018 ◽
Vol 87
(6)
◽
pp. AB55-AB56
◽
2012 ◽
Vol 23
(3)
◽
pp. S150-S151
◽
2015 ◽
Vol 81
(5)
◽
pp. AB327
◽
2014 ◽
Vol 19
(3)
◽
pp. 456-461
◽
2009 ◽
Vol 70
(3)
◽
pp. 445-453
◽